Performed sensitivity analyses indicate that the publication date did not significantly impact meta-analysis results for primary outcomes, including unexplained hypoglycemia, HbA1c, and the total daily insulin dose (Supplementary Figs. S35–S37). The gene discussed is INS; the disease is Hypoglycemia.